BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nakagawa H. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World J Hepatol 2015; 7(17): 2110-2118 [PMID: 26301053 DOI: 10.4254/wjh.v7.i17.2110]
URL: https://www.wjgnet.com/1007-9327/full/v7/i17/2110.htm
Number Citing Articles
1
Jonathan M. Ploeger, Juan C. Manivel, Lauren N. Boatner, Douglas G. Mashek. Caloric Restriction Prevents Carcinogen-Initiated Liver Tumorigenesis in MiceCancer Prevention Research 2017; 10(11): 660 doi: 10.1158/1940-6207.CAPR-17-0174
2
Veronica Jimenez, Claudia Jambrina, Estefania Casana, Victor Sacristan, Sergio Muñoz, Sara Darriba, Jordi Rodó, Cristina Mallol, Miquel Garcia, Xavier León, Sara Marcó, Albert Ribera, Ivet Elias, Alba Casellas, Ignasi Grass, Gemma Elias, Tura Ferré, Sandra Motas, Sylvie Franckhauser, Francisca Mulero, Marc Navarro, Virginia Haurigot, Jesus Ruberte, Fatima Bosch. FGF21 gene therapy as treatment for obesity and insulin resistanceEMBO Molecular Medicine 2018; 10(8) doi: 10.15252/emmm.201708791
3
Fang Wang, Ye Zhang, Jianliang Shen, Bin Yang, Weiwei Dai, Junrong Yan, Sara Maimouni, Heineken Q. Daguplo, Sara Coppola, Yingtang Gao, Yijun Wang, Zhi Du, Kesong Peng, Hui Liu, Qin Zhang, Fei Tang, Peng Wang, Shenglan Gao, Yongbo Wang, Wen-Xing Ding, Grace Guo, Fengmei Wang, Wei-Xing Zong. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant PathwayCellular and Molecular Gastroenterology and Hepatology 2021; 11(5): 1369 doi: 10.1016/j.jcmgh.2021.01.007
4
Marie Liebig, Dirk Dannenberger, Brigitte Vollmar, Kerstin Abshagen. n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse modelTherapeutic Advances in Chronic Disease 2019; 10: 204062231987211 doi: 10.1177/2040622319872118
5
Yusuke Ozawa, Takafumi Tamura, Yohei Owada, Yoshio Shimizu, Akira Kemmochi, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Hiroko Isoda, Nobuhiro Ohkohchi. Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitisWorld Journal of Gastroenterology 2018; 24(15): 1622-1631 doi: 10.3748/wjg.v24.i15.1622
6
Shigeyuki Kurosaki, Hayato Nakagawa, Yuki Hayata, Satoshi Kawamura, Yuki Matsushita, Tomoharu Yamada, Koji Uchino, Yoku Hayakawa, Nobumi Suzuki, Masahiro Hata, Mayo Tsuboi, Hiroto Kinoshita, Yasuo Tanaka, Takuma Nakatsuka, Yoshihiro Hirata, Keisuke Tateishi, Kazuhiko Koike. Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesisJHEP Reports 2021; 3(4): 100315 doi: 10.1016/j.jhepr.2021.100315
7
Michelle Dow, Rachel M. Pyke, Brian Y. Tsui, Ludmil B. Alexandrov, Hayato Nakagawa, Koji Taniguchi, Ekihiro Seki, Olivier Harismendy, Shabnam Shalapour, Michael Karin, Hannah Carter, Joan Font-Burgada. Integrative genomic analysis of mouse and human hepatocellular carcinomaProceedings of the National Academy of Sciences 2018; 115(42): E9879 doi: 10.1073/pnas.1811029115
8
Yvonne P. Dragan. Hepatocellular Carcinoma2016; : 65 doi: 10.1007/978-3-319-34214-6_4
9
Paweł A. Kołodziejski, Ewa Pruszyńska-Oszmałek, Mathias Z. Strowski, Krzysztof W. Nowak. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver functionEndocrine 2017; 56(3): 538 doi: 10.1007/s12020-017-1309-2
10
Stephen L. Chan, Alissa M. Wong, Kirsty Lee, Nathalie Wong, Allen K.C. Chan. Personalized therapy for hepatocellular carcinoma: Where are we now?Cancer Treatment Reviews 2016; 45: 77 doi: 10.1016/j.ctrv.2016.02.008
11
Lichen Bao, Jun Yin, Wen Gao, Qun Wang, Wenbing Yao, Xiangdong Gao. A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathwayBritish Journal of Pharmacology 2018; 175(16): 3379 doi: 10.1111/bph.14383
12
Haider Ghazanfar, Sameer D Kandhi, Iqra Nawaz, Nismat Javed, Minu C Abraham , Mohamed Farag, Jaydeep Mahasamudram, Vishwa B Patel, Faryal Altaf, Harish Patel. Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review ArticleCureus 2021;  doi: 10.7759/cureus.15141
13
Zhi Li, Wen-Qi Gao, Peng Wang, Tian-Qi Wang, Wen-Chao Xu, Xin-Yu Zhu, Hui Liu. Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ SignalingCurrent Cancer Drug Targets 2020; 20(11): 868 doi: 10.2174/1568009620999200730184514
14
James M. Henderson, Natasa Polak, Jinbiao Chen, Ben Roediger, Wolfgang Weninger, James G. Kench, Geoffrey W. McCaughan, Hui Emma Zhang, Mark D. Gorrell. Multiple liver insults synergize to accelerate experimental hepatocellular carcinomaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28486-8
15
Hayato Nakagawa, Yuki Hayata, Satoshi Kawamura, Tomoharu Yamada, Naoto Fujiwara, Kazuhiko Koike. Lipid Metabolic Reprogramming in Hepatocellular CarcinomaCancers 2018; 10(11): 447 doi: 10.3390/cancers10110447
16
Moris Sangineto, Rosanna Villani, Francesco Cavallone, Antonino Romano, Domenico Loizzi, Gaetano Serviddio. Lipid Metabolism in Development and Progression of Hepatocellular CarcinomaCancers 2020; 12(6): 1419 doi: 10.3390/cancers12061419
17
Kenichiro Enooku, Hayato Nakagawa, Naoto Fujiwara, Mayuko Kondo, Tatsuya Minami, Yujin Hoshida, Junji Shibahara, Ryosuke Tateishi, Kazuhiko Koike. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47216-2
18
Satdarshan P. Monga. Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular CancerGene Expression 2020; 20(2): 139 doi: 10.3727/105221620X15913805462476
19
Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David Cassiman, Pieter Spincemaille. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to PresentCurrent Protocols in Mouse Biology 2016; 6(2): 185 doi: 10.1002/cpmo.3
20
Letizia Satriano, Monika Lewinska, Pedro M. Rodrigues, Jesus M. Banales, Jesper B. Andersen. Metabolic rearrangements in primary liver cancers: cause and consequencesNature Reviews Gastroenterology & Hepatology 2019; 16(12): 748 doi: 10.1038/s41575-019-0217-8
21
Nathan A. Berger. Young Adult Cancer: Influence of the Obesity PandemicObesity 2018; 26(4): 641 doi: 10.1002/oby.22137
22
Takahiro Kodama, Jing Yi, Justin Y. Newberg, Jean C. Tien, Hao Wu, Milton J. Finegold, Michiko Kodama, Zhubo Wei, Takeshi Tamura, Tetsuo Takehara, Randy L. Johnson, Nancy A. Jenkins, Neal G. Copeland. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesisProceedings of the National Academy of Sciences 2018; 115(44): E10417 doi: 10.1073/pnas.1808968115
23
Guangyan Wei, Ping An, Kahini A. Vaid, Imad Nasser, Pinzhu Huang, Li Tan, Shuangshuang Zhao, Detlef Schuppan, Yury V. Popov. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancerAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G174 doi: 10.1152/ajpgi.00041.2019
24
Marie Liebig, Alireza Hassanzada, Malte Kämmerling, Berit Genz, Brigitte Vollmar, Kerstin Abshagen. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumorsExperimental Biology and Medicine 2018; 243(1): 1 doi: 10.1177/1535370217738730
25
Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant featuresPathology International 2018; 68(1): 12 doi: 10.1111/pin.12612
26
Run Li, Yaqi Lan, Chengyu Chen, Yong Cao, Qingrong Huang, Chi-Tang Ho, Muwen Lu. Anti-obesity effects of capsaicin and the underlying mechanisms: a reviewFood & Function 2020; 11(9): 7356 doi: 10.1039/D0FO01467B
27
Pavla Staňková, Otto Kučera, Eva Peterová, Halka Lotková, Tumisang Edward Maseko, Kateřina Nožičková, Zuzana Červinková. Adaptation of Mitochondrial Substrate Flux in a Mouse Model of Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2020; 21(3): 1101 doi: 10.3390/ijms21031101
28
Naoto Fujiwara, Hayato Nakagawa, Kenichiro Enooku, Yotaro Kudo, Yuki Hayata, Takuma Nakatsuka, Yasuo Tanaka, Ryosuke Tateishi, Yohko Hikiba, Kento Misumi, Mariko Tanaka, Akimasa Hayashi, Junji Shibahara, Masashi Fukayama, Junichi Arita, Kiyoshi Hasegawa, Hadassa Hirschfield, Yujin Hoshida, Yoshihiro Hirata, Motoyuki Otsuka, Keisuke Tateishi, Kazuhiko Koike. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesityGut 2018; 67(8): 1493 doi: 10.1136/gutjnl-2017-315193
29
C. Nelson Hayes, Peiyi Zhang, Kazuaki Chayama. Hepatocellular Carcinoma2019; : 95 doi: 10.15586/hepatocellularcarcinoma.2019.ch5
30
Hiroyuki Akai, Shigeru Kiryu, Yasunori Ohta, Koichiro Yasaka, Yoshiyasu Nakano, Yusuke Inoue, Kuni Ohtomo. The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis miceMagnetic Resonance Imaging 2017; 38: 123 doi: 10.1016/j.mri.2016.12.027